{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T06:44:40Z","timestamp":1790405080031,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T00:00:00Z","timestamp":1684540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T00:00:00Z","timestamp":1684540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010806","name":"Amgen Nederland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010806","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pilot Feasibility Stud"],"abstract":"<jats:title>Abstract\n<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Patients with multiple myeloma (MM) increasingly face complicated treatment regimens. E-health may support patients and healthcare providers in enhancing a patient-centered healthcare approach. Therefore, we aimed to develop a patient-centered multi-modality e-health application, to assess the application for usability and end-user experiences.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The application was developed following an iterative \u201caction-based\u201d methodology using the design thinking approach. Key end users participated, and relevant stakeholders were consulted in the development process. First, the care pathway was evaluated, the focus of development was determined, and a solution ideated during recurring multidisciplinary meetings. Second, a prototype was tested and improved. Third, a subsequent prototype was evaluated during a pilot study with patients and healthcare professionals on usability, usage, and experiences.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The multi-modality application, named the \u201cMM E-coach,\u201d consisted of a newly developed medication module, patient-reported outcome (PRO) questionnaire assessments, a messaging service, alerts, information provision, and a personal care plan. The median system usability score was 60 on a scale of 0\u2013100. Patients appreciated the medication overview, healthcare professionals appreciated the outpatient clinic preparation module, and both appreciated the messaging service. Additional recommendations for improvement mostly revolved around the flexibility of functionalities and look and feel of the application.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The MM E-coach has the potential to provide patient-centered care by supporting patients and caregivers during MM treatment and is a promising application to be implemented in the MM care pathway. A randomized clinical trial was initiated to study its clinical effectiveness.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40814-023-01307-0","type":"journal-article","created":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T06:02:20Z","timestamp":1684562540000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Rationale and development of an e-health application to deliver patient-centered care during treatment for recently diagnosed multiple myeloma patients: pilot study of the MM E-coach"],"prefix":"10.1186","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1737-7133","authenticated-orcid":false,"given":"Paul","family":"Geerts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Job","family":"Eijsink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albine","family":"Moser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"ter Horst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis","family":"Boersma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten","family":"Postma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,20]]},"reference":[{"issue":"10272","key":"1307_CR1","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/S0140-6736(21)00135-5","volume":"397","author":"NWCJ van de Donk","year":"2021","unstructured":"van de Donk NWCJ, Pawlyn C, Yong KL. Multiple myeloma. The Lancet. 2021;397(10272):410\u201327.","journal-title":"The Lancet"},{"issue":"6","key":"1307_CR2","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1053\/j.seminoncol.2016.11.004","volume":"43","author":"D Kazandjian","year":"2016","unstructured":"Kazandjian D. Multiple myeloma epidemiology and survival: a unique malignancy. Semin Oncol. 2016;43(6):676\u201381.","journal-title":"Semin Oncol"},{"issue":"10218","key":"1307_CR3","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/S0140-6736(19)32956-3","volume":"395","author":"M-V Mateos","year":"2020","unstructured":"Mateos M-V, Cavo M, Blade J, Dimopoulos MA, Suzuki K, Jakubowiak A, Knop S, Doyen C, Lucio P, Nagy Z, Pour L, Cook M, Grosicki S, Crepaldi A, Liberati AM, Campbell P, Shelekhova T, Yoon S-S, Iosava G, Fujisaki T, Garg M, Krevvata M, Chen Y, Wang J, Kudva A, Ukropec J, Wroblewski S, Qi M, Kobos R, San-Miguel J. Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple myeloma (ALCYONE): a randomised, open-label, phase 3 trial. The Lancet. 2020;395(10218):132\u201341.","journal-title":"The Lancet"},{"issue":"10192","key":"1307_CR4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0140-6736(19)31240-1","volume":"394","author":"P Moreau","year":"2019","unstructured":"Moreau P, Attal M, Hulin C, Arnulf B, Belhadj K, Benboubker L, B\u00e9n\u00e9 MC, Broijl A, Caillon H, Caillot D, Corre J, Delforge M, Dejoie T, Doyen C, Facon T, Sonntag C, Fontan J, Garderet L, Jie K-S, Karlin L, Kuhnowski F, Lambert J, Leleu X, Lenain P, Macro M, Mathiot C, Orsini-Piocelle F, Perrot A, Stoppa A-M, van de Donk NWCJ, Wuilleme S, Zweegman S, Kolb B, Touzeau C, Roussel M, Tiab M, Marolleau J-P, Meuleman N, Vekemans M-C, Westerman M, Klein SK, Levin M-D, Fermand JP, Escoffre-Barbe M, Eveillard J-R, Garidi R, Ahmadi T, Zhuang S, Chiu C, Pei L, de Boer C, Smith E, Deraedt W, Kampfenkel T, Schecter J, Vermeulen J, Avet-Loiseau H, Sonneveld P. Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study. The Lancet. 2019;394(10192):29\u201338.","journal-title":"The Lancet"},{"issue":"22","key":"1307_CR5","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1056\/NEJMoa1817249","volume":"380","author":"T Facon","year":"2019","unstructured":"Facon T, Kumar S, Plesner T, Orlowski RZ, Moreau P, Bahlis N, Basu S, Nahi H, Hulin C, Quach H, Goldschmidt H, O\u2019Dwyer M, Perrot A, Venner CP, Weisel K, Mace JR, Raje N, Attal M, Tiab M, Macro M, Frenzel L, Leleu X, Ahmadi T, Chiu C, Wang J, Van Rampelbergh R, Uhlar CM, Kobos R, Qi M, Usmani SZ. Daratumumab plus lenalidomide and dexamethasone for untreated myeloma. N Engl J Med. 2019;380(22):2104\u201315.","journal-title":"N Engl J Med"},{"issue":"11","key":"1307_CR6","doi-asserted-by":"publisher","first-page":"4265","DOI":"10.1007\/s00520-019-04721-4","volume":"27","author":"S Feiten","year":"2019","unstructured":"Feiten S, Chakupurakal G, Feustel HP, Maasberg M, Otremba B, Ehscheidt P, Hensel M, Hansen R, Weide R. High adherence of patients with multiple myeloma who receive treatment with immunomodulatory drugs (IMIDS) in hematology\/oncology group practices in Germany. Support Care Cancer. 2019;27(11):4265\u201371.","journal-title":"Support Care Cancer"},{"key":"1307_CR7","doi-asserted-by":"crossref","unstructured":"Chari A, Romanus D, Palumbo A, Blazer M, Farrelly E, Raju A, Huang H, Richardson P. Randomized clinical trial representativeness and outcomes in real-world patients: comparison of 6 hallmark randomized clinical trials of relapsed\/refractory multiple myeloma. Clin Lymphoma Myeloma Leuk. 2020;20(1):8\u201317 e6.","DOI":"10.1016\/j.clml.2019.09.625"},{"issue":"2","key":"1307_CR8","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41408-021-00432-4","volume":"11","author":"E Terpos","year":"2021","unstructured":"Terpos E, Mikhael J, Hajek R, Chari A, Zweegman S, Lee HC, Mateos MV, Larocca A, Ramasamy K, Kaiser M, Cook G, Weisel KC, Costello CL, Elliott J, Palumbo A, Usmani SZ. Management of patients with multiple myeloma beyond the clinical-trial setting: understanding the balance between efficacy, safety and tolerability, and quality of life. Blood Cancer J. 2021;11(2):40.","journal-title":"Blood Cancer J"},{"issue":"9","key":"1307_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0107828","volume":"9","author":"I Scholl","year":"2014","unstructured":"Scholl I, Zill JM, Harter M, Dirmaier J. An integrative model of patient-centeredness - a systematic review and concept analysis. PLoS ONE. 2014;9(9): e107828.","journal-title":"PLoS ONE"},{"key":"1307_CR10","unstructured":"WHO. Framework on integrated, people-centred health services. Report by the Secretariat.: WHO; 2016. Contract No.: A69\/39."},{"issue":"5","key":"1307_CR11","doi-asserted-by":"publisher","first-page":"e240","DOI":"10.1016\/S1470-2045(20)30021-8","volume":"21","author":"FJ Penedo","year":"2020","unstructured":"Penedo FJ, Oswald LB, Kronenfeld JP, Garcia SF, Cella D, Yanez B. The increasing value of eHealth in the delivery of patient-centred cancer care. Lancet Oncol. 2020;21(5):e240\u201351.","journal-title":"Lancet Oncol"},{"key":"1307_CR12","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1200\/CCI.20.00145","volume":"5","author":"S Jagannath","year":"2021","unstructured":"Jagannath S, Mikhael J, Nadeem O, Raje N. Digital health for patients with multiple myeloma: an unmet need. JCO Clinical Cancer Informatics. 2021;5:1096\u2013105.","journal-title":"JCO Clinical Cancer Informatics"},{"issue":"6","key":"1307_CR13","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1200\/JCO.2015.63.0830","volume":"34","author":"E Basch","year":"2016","unstructured":"Basch E, Deal AM, Kris MG, Scher HI, Hudis CA, Sabbatini P, Rogak L, Bennett AV, Dueck AC, Atkinson TM, Chou JF, Dulko D, Sit L, Barz A, Novotny P, Fruscione M, Sloan JA, Schrag D. Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol. 2016;34(6):557\u201365.","journal-title":"J Clin Oncol"},{"issue":"5","key":"1307_CR14","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1007\/s00520-015-3004-2","volume":"24","author":"S Duman-Lubberding","year":"2016","unstructured":"Duman-Lubberding S, van Uden-Kraan CF, Jansen F, Witte BI, van der Velden LA, Lacko M, Cuijpers P, Leemans CR, Verdonck-de Leeuw IM. Feasibility of an eHealth application \u201cOncokompas\u201d to improve personalized survivorship cancer care. Support Care Cancer. 2016;24(5):2163\u201371.","journal-title":"Support Care Cancer"},{"issue":"7","key":"1307_CR15","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1080\/0284186X.2018.1438654","volume":"57","author":"HC Melissant","year":"2018","unstructured":"Melissant HC, Verdonck-de Leeuw IM, Lissenberg-Witte BI, Konings IR, Cuijpers P, Van Uden-Kraan CF. \u2018Oncokompas\u2019, a web-based self-management application to support patient activation and optimal supportive care: a feasibility study among breast cancer survivors. Acta Oncol. 2018;57(7):924\u201334.","journal-title":"Acta Oncol"},{"issue":"6","key":"1307_CR16","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.4255","volume":"17","author":"T Irizarry","year":"2015","unstructured":"Irizarry T, DeVito DA, Curran CR. Patient portals and patient engagement: a state of the science review. J Med Internet Res. 2015;17(6): e148.","journal-title":"J Med Internet Res"},{"issue":"3","key":"1307_CR17","doi-asserted-by":"publisher","DOI":"10.2196\/mhealth.6432","volume":"6","author":"I Ahmed","year":"2018","unstructured":"Ahmed I, Ahmad NS, Ali S, Ali S, George A, Saleem Danish H, Uppal E, Soo J, Mobasheri MH, King D, Cox B, Darzi A. Medication adherence apps: review and content analysis. JMIR Mhealth Uhealth. 2018;6(3): e62.","journal-title":"JMIR Mhealth Uhealth"},{"issue":"1","key":"1307_CR18","doi-asserted-by":"publisher","DOI":"10.2196\/18901","volume":"23","author":"BPH Pouls","year":"2021","unstructured":"Pouls BPH, Vriezekolk JE, Bekker CL, Linn AJ, van Onzenoort HAW, Vervloet M, van Dulmen S, van den Bemt BJF. Effect of interactive eHealth interventions on improving medication adherence in adults with long-term medication: systematic review. J Med Internet Res. 2021;23(1): e18901.","journal-title":"J Med Internet Res"},{"issue":"5","key":"1307_CR19","doi-asserted-by":"publisher","DOI":"10.2196\/10235","volume":"20","author":"C Granja","year":"2018","unstructured":"Granja C, Janssen W, Johansen MA. Factors determining the success and failure of eHealth interventions: systematic review of the literature. J Med Internet Res. 2018;20(5): e10235.","journal-title":"J Med Internet Res"},{"key":"1307_CR20","doi-asserted-by":"publisher","first-page":"E117","DOI":"10.5888\/pcd15.180128","volume":"15","author":"M Altman","year":"2018","unstructured":"Altman M, Huang TTK, Breland JY. Design thinking in health care. Prev Chronic Dis. 2018;15:E117.","journal-title":"Prev Chronic Dis"},{"key":"1307_CR21","doi-asserted-by":"crossref","unstructured":"van Dijk-de Vries A, Stevens A, van der Weijden T, Beurskens A. How to support a co-creative research approach in order to foster impact. The development of a Co-creation Impact Compass for healthcare researchers. PLoS One. 2020;15(10):e0240543.","DOI":"10.1371\/journal.pone.0240543"},{"key":"1307_CR22","doi-asserted-by":"crossref","unstructured":"Gemert-Pijnen L, Kelders SM, Kip H, Sanderman R. eHealth development, implementation and evaluation. eHealth RESEARCH, THEORY AND DEVELOPMENT: A MULTIDISCIPLINARY APPRoach. 1. 1 ed. New York: Routledge; 2018. p. 159\u2013355.","DOI":"10.4324\/9781315385907"},{"issue":"4","key":"1307_CR23","doi-asserted-by":"publisher","DOI":"10.2196\/14376","volume":"8","author":"G Molina-Recio","year":"2020","unstructured":"Molina-Recio G, Molina-Luque R, Jimenez-Garcia AM, Ventura-Puertos PE, Hernandez-Reyes A, Romero-Saldana M. Proposal for the user-centered design approach for health apps based on successful experiences: integrative review. JMIR Mhealth Uhealth. 2020;8(4): e14376.","journal-title":"JMIR Mhealth Uhealth"},{"key":"1307_CR24","first-page":"506","volume-title":"Redefining healthcare: creating value-based competition on results","author":"ME Porter","year":"2006","unstructured":"Porter ME, Teisberg EO. Redefining healthcare: creating value-based competition on results. Boston, Massachusetts: Harvard Business School Press; 2006. p. 506."},{"issue":"4","key":"1307_CR25","doi-asserted-by":"publisher","DOI":"10.2196\/15780","volume":"8","author":"IC Hou","year":"2020","unstructured":"Hou IC, Lan MF, Shen SH, Tsai PY, Chang KJ, Tai HC, Tsai AJ, Chang P, Wang TF, Sheu SJ, Dykes PC. The development of a mobile health app for breast cancer self-management support in Taiwan: design thinking approach. JMIR Mhealth Uhealth. 2020;8(4): e15780.","journal-title":"JMIR Mhealth Uhealth"},{"issue":"9","key":"1307_CR26","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1080\/14719037.2014.930505","volume":"17","author":"WH Voorberg","year":"2014","unstructured":"Voorberg WH, Bekkers VJJM, Tummers LG. A systematic review of co-creation and co-production: embarking on the social innovation journey. Public Manag Rev. 2014;17(9):1333\u201357.","journal-title":"Public Manag Rev"},{"issue":"4","key":"1307_CR27","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1111\/hex.12671","volume":"21","author":"M de Wit","year":"2018","unstructured":"de Wit M, Beurskens A, Piskur B, Stoffers E, Moser A. Preparing researchers for patient and public involvement in scientific research: development of a hands-on learning approach through action research. Health Expect. 2018;21(4):752\u201363.","journal-title":"Health Expect"},{"key":"1307_CR28","unstructured":"HOVON Myeloom Werkgroep. Myeloma treatment guidelines 2021 [Available from: https:\/\/hovon.nl\/en\/treatment-guidelines\/myeloma]."},{"issue":"9","key":"1307_CR29","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1177\/1049732305276687","volume":"15","author":"HF Hsieh","year":"2005","unstructured":"Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15(9):1277\u201388.","journal-title":"Qual Health Res"},{"issue":"12","key":"1307_CR30","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","volume":"15","author":"SV Rajkumar","year":"2014","unstructured":"Rajkumar SV, Dimopoulos MA, Palumbo A, Blade J, Merlini G, Mateos M-V, Kumar S, Hillengass J, Kastritis E, Richardson P, Landgren O, Paiva B, Dispenzieri A, Weiss B, LeLeu X, Zweegman S, Lonial S, Rosinol L, Zamagni E, Jagannath S, Sezer O, Kristinsson SY, Caers J, Usmani SZ, Lahuerta JJ, Johnsen HE, Beksac M, Cavo M, Goldschmidt H, Terpos E, Kyle RA, Anderson KC, Durie BGM, Miguel JFS. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15(12):e538\u201348.","journal-title":"Lancet Oncol"},{"issue":"194","key":"1307_CR31","first-page":"4","volume":"189","author":"J Brooke","year":"1996","unstructured":"Brooke J. SUS \u2014 a quick and dirty usability scale. Usability evaluation in industry. 1996;189(194):4\u20137.","journal-title":"Usability evaluation in industry"},{"key":"1307_CR32","doi-asserted-by":"crossref","unstructured":"Sousa VEC, Dunn Lopez K. Towards usable e-health. A systematic review of usability questionnaires. Appl Clin Inform. 2017;8(2):470\u201390.","DOI":"10.4338\/ACI-2016-10-R-0170"},{"issue":"3","key":"1307_CR33","first-page":"114","volume":"4","author":"A Bangor","year":"2009","unstructured":"Bangor A, Kortum P, Miller J. Determining what inidividual SUS scores mean: adding an adjective rating scale. J Usability Stud. 2009;4(3):114\u201323.","journal-title":"J Usability Stud"},{"issue":"5","key":"1307_CR34","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","volume":"85","author":"NK Aaronson","year":"1993","unstructured":"Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, De Haes JC, Kaasa S, Klee M, Osoba D, Razavi D, Rofe PB, Schraub S, Sneeuw K, Sullivan M, Takeda F. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in International Clinical Trials in oncology. J Natl Cancer Inst. 1993;85(5):365\u201376.","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"1307_CR35","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","volume":"20","author":"M Herdman","year":"2011","unstructured":"Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, Bonsel G, Badia X. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727\u201336.","journal-title":"Qual Life Res"},{"issue":"7","key":"1307_CR36","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1111\/bcp.14193","volume":"86","author":"AHY Chan","year":"2020","unstructured":"Chan AHY, Horne R, Hankins M, Chisari C. The Medication Adherence Report Scale: a measurement tool for eliciting patients\u2019 reports of nonadherence. Br J Clin Pharmacol. 2020;86(7):1281\u20138.","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"1307_CR37","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1370\/afm.1713","volume":"12","author":"T Bodenheimer","year":"2014","unstructured":"Bodenheimer T, Sinsky C. From triple to quadruple aim: care of the patient requires care of the provider. Ann Fam Med. 2014;12(6):573\u20136.","journal-title":"Ann Fam Med"},{"issue":"5","key":"1307_CR38","doi-asserted-by":"publisher","DOI":"10.2196\/15895","volume":"22","author":"GI Ector","year":"2020","unstructured":"Ector GI, Westerweel PE, Hermens RP, Braspenning KA, Heeren BC, Vinck OM, de Jong JJ, Janssen JJ, Blijlevens NM. The development of a web-based, patient-centered intervention for patients with chronic myeloid leukemia (CMyLife): design thinking development approach. J Med Internet Res. 2020;22(5): e15895.","journal-title":"J Med Internet Res"},{"issue":"7","key":"1307_CR39","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.5877","volume":"18","author":"IR van Bruinessen","year":"2016","unstructured":"van Bruinessen IR, van Weel-Baumgarten EM, Gouw H, Zijlstra JM, van Dulmen S. An integrated process and outcome evaluation of a web-based communication tool for patients with malignant lymphoma: randomized controlled trial. J Med Internet Res. 2016;18(7): e206.","journal-title":"J Med Internet Res"},{"key":"1307_CR40","unstructured":"Patientslikeme 2022 [Available from: https:\/\/www.patientslikeme.com]."},{"issue":"10","key":"1307_CR41","doi-asserted-by":"publisher","DOI":"10.2196\/24722","volume":"23","author":"M Marthick","year":"2021","unstructured":"Marthick M, McGregor D, Alison J, Cheema B, Dhillon H, Shaw T. Supportive care interventions for people with cancer assisted by digital technology: systematic review. J Med Internet Res. 2021;23(10): e24722.","journal-title":"J Med Internet Res"},{"issue":"2","key":"1307_CR42","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1001\/jama.2017.7156","volume":"318","author":"E Basch","year":"2017","unstructured":"Basch E, Deal AM, Dueck AC, Scher HI, Kris MG, Hudis C, Schrag D. Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. JAMA. 2017;318(2):197\u20138.","journal-title":"JAMA"},{"issue":"2","key":"1307_CR43","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1111\/1468-0009.12197","volume":"94","author":"T Greenhalgh","year":"2016","unstructured":"Greenhalgh T, Jackson C, Shaw S, Janamian T. Achieving research impact through co-creation in community-based health services: literature review and case study. Milbank Q. 2016;94(2):392\u2013429.","journal-title":"Milbank Q"},{"issue":"4","key":"1307_CR44","first-page":"216","volume":"35","author":"SR Arnstein","year":"1969","unstructured":"Arnstein SR. A ladder of citizen participation. JAIP. 1969;35(4):216\u201324.","journal-title":"JAIP"},{"issue":"4","key":"1307_CR45","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.1672","volume":"13","author":"JE van Gemert-Pijnen","year":"2011","unstructured":"van Gemert-Pijnen JE, Nijland N, van Limburg M, Ossebaard HC, Kelders SM, Eysenbach G, Seydel ER. A holistic framework to improve the uptake and impact of eHealth technologies. J Med Internet Res. 2011;13(4): e111.","journal-title":"J Med Internet Res"},{"issue":"4","key":"1307_CR46","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.1674","volume":"13","author":"M van Limburg","year":"2011","unstructured":"van Limburg M, van Gemert-Pijnen JE, Nijland N, Ossebaard HC, Hendrix RM, Seydel ER. Why business modeling is crucial in the development of eHealth technologies. J Med Internet Res. 2011;13(4): e124.","journal-title":"J Med Internet Res"},{"issue":"1","key":"1307_CR47","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12911-019-0868-y","volume":"19","author":"PAF Geerts","year":"2019","unstructured":"Geerts PAF, van der Weijden T, Loeffen PGM, Janssen LEF, Almekinders C, Wienhold TA, Bos GMJ. Developing a patient portal for haematology patients requires involvement of all stakeholders and a customised design, tailored to the individual needs. BMC Med Inform Decis Mak. 2019;19(1):129.","journal-title":"BMC Med Inform Decis Mak"},{"issue":"1","key":"1307_CR48","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s13187-017-1293-5","volume":"34","author":"H Kim","year":"2019","unstructured":"Kim H, Goldsmith JV, Sengupta S, Mahmood A, Powell MP, Bhatt J, Chang CF, Bhuyan SS. Mobile health application and e-health literacy: opportunities and concerns for cancer patients and caregivers. J Cancer Educ. 2019;34(1):3\u20138.","journal-title":"J Cancer Educ"}],"container-title":["Pilot and Feasibility Studies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40814-023-01307-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40814-023-01307-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40814-023-01307-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T07:01:47Z","timestamp":1684566107000},"score":1,"resource":{"primary":{"URL":"https:\/\/pilotfeasibilitystudies.biomedcentral.com\/articles\/10.1186\/s40814-023-01307-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,20]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1307"],"URL":"https:\/\/doi.org\/10.1186\/s40814-023-01307-0","relation":{},"ISSN":["2055-5784"],"issn-type":[{"value":"2055-5784","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,20]]},"assertion":[{"value":"31 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Medical Research Ethics Committee (METC) of Isala Klinieken, which waived the requirement for obtaining informed consent, approved the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"N\/a.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"85"}}